FLEXYTE® Assays

Developed utilising Almac's experience in peptide engineering and chemical synthesis and design, FLEXYTE® assays harness the power and potential of fluorescence lifetime technology (FLT) to provide a robust, efficient and economical platform for screening and profiling. The evolving assay platform offers assay solutions for many major therapeutic target classes including kinases, proteases, phosphatases and an increasing number of epigenetic targets.

For latest product information view our Flexyte Product Sheet.

Talk to an expert – The FLEXYTE® team will be attending the SLAS 2012 convention in San Diego February 4-8th where they will be presenting a tutorial on FLT. For details please see the FLT tutorial invitation.

Benefits of FLT:

  1. Robust and reliable
  2. Homogenous antibody free assays
  3. Avoids use of  radioactivity
  4. Allows miniaturisation
  5. Minimises interference from problem compounds
  6. Enables multiplexing

NOW Available – FLT Webinar